Expiration date: 04/2022
Structure and Composition:
2.5 mg of aqueous-alcoholic gel containing 1.5 mg of estradiol in tubes of 80 g with a measured spatula.
Description of the pharmacological actions:
Reduces or eliminates the symptoms of climacteric syndrome (including osteoporosis) improves the lipid profile (normalizes triatsilglitsiridov), reduces platelet aggregation, blood viscosity.
The effect is 7-10 days after application.
Estrogen deficit state (sensation of heat, sweating, sleep disturbances, dizziness, irritability, atrophic changes of the organs of the urogenital system), post-menopausal osteoporosis (prevention).
Malignant tumors of the breast and endometrium, severe liver dysfunction, uterine bleeding unclear etiology, thromboembolic disease, pregnancy.
Headache, nausea, breast tension, spotting, glandular hyperplasia of the endometrium, skin irritation.
Dosage and administration:
Outwardly, constantly or cyclically, a standard dose of the gel (2.5 - 1.5 mg of estradiol) is applied once daily to the skin as much as possible areas (arms, legs or abdomen). Treatment supplemented progestin drugs (10 days 1-3 months).
It is recommended to avoid contact with the gel to the skin of the mammary glands and genitals.